Prediction of Chemosensitivity in Multiple Primary Cancer Patients Using Machine Learning
Authors:
- 5 May 2021
- journal article
- research article
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 41 (5) , 2419-2429
Abstract
Background/Aim: Many cancer patients face multiple primary cancers. It is challenging to find an anticancer therapy that covers both cancer types in such patients. In personalized medicine, drug response is predicted using genomic information, which makes it possible to choose the most effective therapy for these cancer patients. The aim of this study was to identify chemosensitive gene sets and compare the predictive accuracy of response of cancer cell lines to drug treatment, based on both the genomic features of cell lines and cancer types. Materials and Methods: In this study, we identified a gene set that is sensitive to a specific therapeutic drug, and compared the performance of several predictive models using the identified genes and cancer types through machine learning (ML). To this end, publicly available gene expression datasets and drug sensitivity datasets of gastric and pancreatic cancers were used. Five ML algorithms, including linear discriminant analysis, classification and regression tree, k-nearest neighbors, support vector machine and random forest, were implemented. Results: The predictive accuracy of the cancer type models were 0.729 to 0.763 on the training dataset and 0.731 to 0.765 on the testing dataset. The predictive accuracy of the genomic prediction models was 0.818 to 1.0 on the training dataset and 0.759 to 0.896 on the testing dataset. Conclusion: Performance of the specific gene models was much better than those of the cancer type models using the ML methods. Therofore, the most effective therapeutic drug can be chosen based on the expression of specific genes in patients with multiple primary cancers, regardless of cancer types.Keywords
This publication has 52 references indexed in Scilit:
- HPV Status and second primary tumours in Oropharyngeal Squamous Cell CarcinomaJournal of Otolaryngology - Head & Neck Surgery, 2013
- Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literatureCurrent Medical Research and Opinion, 2012
- Preparing for Precision MedicineNew England Journal of Medicine, 2012
- The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort studyBMC Cancer, 2011
- Multiple tumours in survival estimatesEuropean Journal of Cancer, 2009
- Longitudinal study of smoking patterns in relation to the development of smoking‐related secondary primary tumors in patients with upper aerodigestive tract malignanciesCancer, 2004
- Decreased Absolute Counts of T Lymphocyte Subsets and Their Relation to Disease in Squamous Cell Carcinoma of the Head and NeckClinical Cancer Research, 2004
- The random subspace method for constructing decision forestsIEEE Transactions on Pattern Analysis and Machine Intelligence, 1998
- Support-vector networksMachine Learning, 1995
- An Introduction to Kernel and Nearest-Neighbor Nonparametric RegressionThe American Statistician, 1992